Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Disrupting Cell Engineering with Non-Viral Modalities

September 30, 2021 | CRISPR, Impetus Digital, Jessica Schwaber, Natalie Yeadon, Solupore, allogeneic therapies, cell engineering, cell therapy, gene therapy, gene-editing, non-viral modalities, precision medicine, viral modalities 

Jessica Schwaber, Scientific Director, Cell & Gene Therapy, Avectas, explores her company’s unique cell engineering platform, the recent shift in cell & gene therapy commercial needs, current barriers to realizing the full potential of cell & gene therapy, and much more.

This content was provided by Impetus Digital

Company Details

- PMLiVE

Impetus Digital

Email
Website

 Latest Content from  Impetus Digital 

Supporting Mental Health During a Global Pandemic

Sam Duboc, Chair & CEO of MindBeacon, explores virtual care and telehealth for treating depression, anxiety, addiction, and other conditions; mental health issues brought on by COVID-19; and how to…

Driving Digital Transformation in Healthcare Using AI

Tom Lawry, National Director for AI, Health & Life Sciences at Microsoft, shares how he helps life science companies implement innovative analytical solutions, the current barriers to enterprise-wide adoption of…

Blockchain in Healthcare: Predictions for the Post-COVID World

Dr. Jody Ranck, EVP, Global Strategy at Ram Global, discusses the novel ThEA diagnostic platform for rapid COVID-19 testing. He will also share his expertise on digital health, innovation, connected…

AI-Driven Customer Journey Mapping in Biopharma

Philip Poulidis (CEO & Co-founder) and Orchid Jahanshahi (VP, Life Sciences) from ODAIA explores AI and big data for customer journey mapping and dynamic segmentation, data integration, omni-channel customer engagement,…

Virtual MSL training on the Impetus InSite Platform®: A Customer Story

How a client used our award-winning virtual engagement and learning tools to produce a series of online training modules.

Digital Health for Improving Care in Disadvantaged Populations

Peter Wood (Co-founder & COO) and Dr. Raj Padwal (Co-founder & CEO) from mmHg Inc. explain how their Sphygmo virtual care system can be used to monitor blood pressure, glucose,…

The Future of Digital Pills

Valerie Sullivan, President and CEO at etectRx, dives into digital pills in healthcare and clinical research. Among many other things, we discuss how Pharma companies can benefit from the ability…

Improving Healthcare Access & Consumer Choice Through Digital Health

Erin Russell, Founder and CEO of Health Grizzly, shares her company’s approach to improving healthcare access and consumer choice through digital health. She also explores digital transformation in healthcare, how…

Improving Public Health Through Telemedicine

Laurence Girard, CEO of Fruit Street Health, shares his tips for aspiring HealthTech entrepreneurs, his views on the future of telemedicine and digital health, and why he thinks healthcare companies…

Social Media, Wearable Technologies, and AI

João Bocas, CEO, Keynote Speaker, Social Media Influencer & Advisor at Digital Salutem, shares his thoughts on several intriguing topics related to wearables, AI, machine learning, robotics, and other digital…